R97.2
Elevated prostate specific antigen [PSA]
Clinical Classification Guidelines
Medical Intelligence & Overview
An elevated prostate specific antigen (PSA) is a medical condition characterized by higher-than-normal levels of PSA in the blood. PSA is a protein produced primarily by the prostate gland, and its measurement is often used to screen for prostate health issues, including prostate cancer, benign prostatic hyperplasia, or inflammation. The ICD-10 code R97.2 specifically denotes cases where PSA levels are elevated without a definitive diagnosis of cancer or other conditions at the time of testing, serving as an important marker for further investigation and monitoring.
Causes & Symptoms
Clinical Causes: Prostate cancer or other prostate malignancies Benign prostatic hyperplasia (enlargement of the prostate) Prostatitis (inflamation or infection of the prostate gland) Recent prostate manipulation or injury Urinary tract infection Age-related prostate changes Certain medical procedures involving the prostate Ejaculation or sexual activity shortly before testing
Key Symptoms: No noticeable symptoms in early stages Difficulty urinating or weak urine flow Frequent urination, especially at night Pain or burning during urination Blood in urine or semen Discomfort or pain in the pelvic region Unexplained weight loss or fatigue in advanced cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of elevated PSA levels begins with a blood test measuring PSA concentration. If levels are elevated, further steps may include a digital rectal exam (DRE) to assess prostate size and texture. Additional diagnostic procedures, such as prostate biopsy, imaging tests (like ultrasound or MRI), and repeat PSA testing, might be recommended to establish the underlying cause of the elevation and determine if more serious conditions are present.
Treatment Protocols: Treatment options for elevated PSA depend on the underlying cause. They may involve active surveillance, medication, or surgical intervention. Options include: - Watchful waiting or active surveillance for mild or unclear cases - Medications, such as alpha-blockers or 5-alpha-reductase inhibitors - Surgical options, including procedures to reduce prostate size or remove affected tissue - Addressing infections with antibiotics - Lifestyle modifications to manage symptoms It is essential to consult a healthcare professional for an individualized approach tailored to the patient's health status and underlying condition.
Clinical Advice & FAQs
Billing Guidance
Is R97.2 a billable ICD-10 code?
Yes, R97.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R97.2?
Clinical documentation must specify the nature of Elevated prostate specific antigen [PSA] and any associated comorbidities for accurate reporting.
Cite this Clinical Reference